EGFR and breast cancer: Reduction of Ki-67 was reported in TNBC tumors treated with gefitinib and with an EGFR inhibitor in combination with fingolimod, as well as in human BC cell xenograft tumors treated with platycodin D [68,75], reinforcing our conclusions of significant decreases in tumor cells proliferation.